000			01514 a2200397 4500
005			20250515113737.0
264		0	_c20080804
008			200808s 0 0 eng d
022			_a1023-3830
024	7		_a10.1007/s00011-007-7134-y _2doi
040			_aNLM _beng _cNLM
100	1		_aFuentes, J M
245	0	0	_aAtropine treatment modifies LPS-induced inflammatory response and increases survival. _h[electronic resource]
260			_bInflammation research : official journal of the European Histamine Research Society ... [et al.] _cMar 2008
300			_a111-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAtropine _xmetabolism
650	0	4	_aInterleukin-10 _ximmunology
650	0	4	_aInterleukin-6 _ximmunology
650	0	4	_aLipopolysaccharides _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMuscarinic Antagonists _xmetabolism
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aShock, Septic _ximmunology
650	0	4	_aSurvival Rate
650	0	4	_aTumor Necrosis Factor-alpha _ximmunology
700	1		_aFulton, W B
700	1		_aNino, D
700	1		_aTalamini, M A
700	1		_aMaio, A De
773	0		_tInflammation research : official journal of the European Histamine Research Society ... [et al.] _gvol. 57 _gno. 3 _gp. 111-7
856	4	0	_uhttps://doi.org/10.1007/s00011-007-7134-y _zAvailable from publisher's website
999			_c17869717 _d17869717